Search
for
Sort by
Research 331–360 of 341
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- Beyond Minoxidil: Off-Label Therapies for Male Androgenetic Alopecia—A Systematic Review with Network Meta-Analyses
- Serum and hair steroid profiles and their associations with body composition in adolescence
- Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study
- Changes in bone mineral density in women with early-onset androgenetik alopecia and their correlations with hair-loss stages: a cross-sectional study
- Clinical Usefulness of Plasma Androstanediol Glucuronide Measurements in Women with Idiopathic Hirsutism*
- 6 Peripheral androgens and the role of androstanediol glucuronide
- Androstanediolglucuronide: A parameter for peripheral androgen activity before and during therapy with cyproterone acetate
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- Correlation of Serum 3<i>α</i>-Androstanediol Glucuronide with Acne and Chest Hair Density in Men
- Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness
- Evidence of Increased 3‐Alpha‐Androstanediol Glucuronide in Female Pattern Alopecia: A Cross‐Sectional Observational Study Evaluating Ovarian, Adrenal, and Peripheral Androgens
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Effect of Leuprolide and Dexamethasone on Hair Growth and Hormone Levels in Hirsute Women: The Relative Importance of the Ovary and the Adrenal in the Pathogenesis of Hirsutism*
- Androgen Conjugates: Physiology and Clinical Significance
- Metformin influence on hormone levels at birth, in PCOS mothers and their newborns
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Markers of peripheral androgen action in vivo and in vitro
- Diagnosis of hyperandrogenism: Biochemical criteria
- Clinical and Biochemical Parameters of Androgen Action in Normal Healthy Caucasian<i>Versus</i>Chinese Subjects
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- The SAHA Syndrome
- Alterations in androgen conjugate levels in women and men with alopecia